An automatic analysis system for chromosomal abnormalities based on STR data

By developing an automated chromosomal abnormality analysis system based on STR data, the entire process from raw CSV files to chromosomal abnormality diagnosis has been automated, solving the problems of low efficiency and insufficient accuracy in existing STR data analysis methods and improving detection efficiency and accuracy.

CN123072779APending Publication Date: 2026-11-10GUANGZHOU HYBRIBIO MEDICINE TECH LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611036507.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-07-13
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing STR data analysis methods rely heavily on manual interpretation, resulting in low detection efficiency and difficulty in ensuring the consistency and accuracy of results.

Method used

Develop an automated chromosomal abnormality analysis system based on STR data, including a data reading and processing module, an intelligent analysis module, and an automatic diagnosis module. This system automates the entire process from raw CSV files to chromosomal abnormality diagnosis and combines multi-level interpretation rules for intelligent interpretation.

Benefits of technology

It greatly improves detection efficiency, significantly reduces false positives and false negatives, enhances the accuracy and consistency of analysis results, and supports batch processing and standardized report output.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123072779A_ABST
    Figure CN123072779A_ABST
Patent Text Reader

Abstract

The present application relates to the technical field of biological information, and discloses a chromosome abnormality automatic analysis system based on STR data, which comprises: a data reading and processing module, which is used for reading STR original data to be analyzed; is also used for pre-processing the STR original data to be analyzed, extracting key parameters from the pre-processed STR data to be analyzed, and obtaining target standard data; an intelligent analysis module, which is used for determining peak type distribution data of each group of chromosomes based on the target standard data; and an automatic diagnosis module, which is used for determining a chromosome analysis result corresponding to each group of chromosomes according to a preset multi-level interpretation rule and the peak type distribution data corresponding to each group of chromosomes. The present application can automatically complete the whole process from original file import to chromosome abnormality diagnosis, does not need manual statistics of peak types of sites, greatly improves the detection efficiency, and significantly improves the accuracy through comprehensive interpretation of the peak type distribution data of sites.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of bioinformatics, specifically to an automated chromosomal abnormality analysis system based on STR data. Background Technology

[0002] Chromosomal aneuploidy is one of the core causes of birth defects and hereditary diseases in newborns. Traditional chromosome karyotype analysis techniques require in vitro culture of sample cells, which has problems such as long testing cycles and cumbersome experimental procedures.

[0003] In recent years, molecular diagnostic techniques based on short tandem repeats (STRs) have been widely used in prenatal diagnosis due to their fast detection speed and high accuracy.

[0004] However, current mainstream STR data analysis methods still heavily rely on manual interpretation, requiring professional technicians to identify and analyze the peak patterns of STR loci one by one. This not only involves a huge workload and low detection efficiency, but is also easily affected by the subjective judgment of technicians, resulting in poor consistency of test results and difficulty in guaranteeing accuracy. Summary of the Invention

[0005] This invention provides an automated chromosomal abnormality analysis system based on STR data to address the problems of low accuracy and efficiency in existing STR data analysis methods.

[0006] In a first aspect, the present invention provides an automated chromosomal abnormality analysis system based on STR data, the system comprising: The data reading and processing module is used to read the raw STR data to be analyzed; it is also used to preprocess the raw STR data to be analyzed, and then extract key parameters from the preprocessed STR data to obtain target standard data; the key parameters include loci and peak data. The intelligent analysis module, connected to the data reading and processing module, is used to determine the peak distribution data of loci on each group of chromosomes based on the target standard data. The automatic diagnosis module, connected to the intelligent analysis module, is used to determine the chromosome analysis results for each group of chromosomes based on preset multi-level interpretation rules and the peak distribution data corresponding to each group of chromosomes.

[0007] The automatic chromosome abnormality analysis system provided by this invention can automatically complete the entire process from importing the original CSV file to chromosomal abnormality diagnosis, eliminating the need for manual statistical analysis of locus peaks and greatly improving detection efficiency. Furthermore, by comprehensively interpreting the locus peak distribution data, it significantly reduces false positives and false negatives caused by errors at a single locus, resulting in a significant improvement in accuracy.

[0008] In one alternative implementation, the system further includes: The result verification and editing module is used to visually display the output data of at least one of the data reading and processing module, intelligent analysis module, and automatic diagnosis module; it is also used to respond to user operation commands to enable data editing. The report generation module is used to receive output data from at least one of the data reading and processing module, intelligent analysis module, automatic diagnosis module, and result review and editing module, and generate a standardized diagnostic report based on the received data.

[0009] This invention enables automated analysis and intelligent interpretation of STR data, significantly reducing the analysis time for a single sample, improving the efficiency and accuracy of prenatal chromosome analysis, and supporting batch processing and standardized report output, thereby enhancing the consistency of analysis results.

[0010] In one alternative implementation, the intelligent analysis module includes: The main peak number identification unit is used to identify the number of main peaks corresponding to each point on each chromosome based on the target standard data; The ratio calculation unit is used to determine the peak area ratio of a corresponding site based on the target standard data, when the number of main peaks corresponding to the site is greater than 1. The peak shape recognition unit is used to determine the peak shape of each point on each group of chromosomes based on the number of main peaks, the peak area ratio, and the preset chromosome multi-level ratio rules, and to generate peak shape distribution data.

[0011] In one optional implementation, the peak shape recognition unit is specifically used for: If the number of main peaks is 0, skip the peak shape judgment and return an empty value; When the number of main peaks is 1, the peak shape at the corresponding location is determined to be an invalid peak shape; When the number of main peaks is greater than 1, the peak area ratio is matched with the corresponding preset chromosome multi-level ratio rule according to the chromosome type of each group to determine the peak type of the corresponding site as one of the three-body peak type, intermediate peak type, or normal peak type.

[0012] In one optional implementation, the preset chromosome multi-level ratio rule includes multiple ratio intervals divided according to the number of main peaks at different chromosome types, wherein each ratio interval corresponds to a peak type.

[0013] In one optional implementation, the ratio calculation unit is specifically used for: When the number of main peaks corresponding to a site is greater than 1, calculate the first ratio and the second ratio of the corresponding site; where the first ratio is the ratio between the maximum peak area and the minimum peak area, and the second ratio is the ratio between the minimum peak area and the maximum peak area. The first ratio and the second ratio are used together as the peak area ratio.

[0014] In one optional implementation, when the chromosome is chromosome 21, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 21 on chromosome 21, the diagnosis is trisomy 21 positive. If there are 7 invalid peaks on chromosome 21, the diagnosis is either monosomy of chromosome 21 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 21, it is interpreted as possible trisomy 21 mosaicism. If there are ≥2 normal peaks on chromosome 21, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 21 and 6 invalid peaks, the diagnosis is trisomy 21 negative. If chromosome 21 does not meet any of the above conditions, the result should be interpreted as chromosome 21 requiring verification.

[0015] In one optional implementation, when the chromosome is chromosome 18, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 18 on chromosome 18, the diagnosis is trisomy 18 positive. If there are 5 invalid peaks on chromosome 18, the diagnosis is either monosomy of chromosome 18 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 18, it is interpreted as possible trisomy 18 mosaicism. If there are ≥2 normal peaks on chromosome 18, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 18 and 4 invalid peaks, the diagnosis is trisomy 18 negative. If chromosome 18 does not meet any of the above conditions, the result should be interpreted as chromosome 18 requiring verification.

[0016] In one optional implementation, when the chromosome is chromosome 13, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 13 peaks on chromosome 13, the diagnosis is trisomy 13 positive. If there are 5 invalid peaks on chromosome 13, the diagnosis is either monosomy of chromosome 13 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 13, it is interpreted as possible trisomy 13 mosaicism. If there are ≥2 normal peaks on chromosome 13, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 13 and 4 invalid peaks, the diagnosis is trisomy 13 negative. If chromosome 13 does not meet any of the above conditions, the result should be interpreted as chromosome 13 requiring verification.

[0017] In one optional implementation, when the chromosome is a sex chromosome, the preset multi-level interpretation rules include: First interpretation rule: Locus AMEL shows an invalid peak pattern; loci SRY and DYS448 show no peak; locus TAF9B shows a normal peak pattern or an intermediate peak pattern; loci DXS981, DXYS267, DXYS218, and DXS1187 show a normal peak pattern, an invalid peak pattern, or an intermediate peak pattern; among loci TAF9B, DXS981, DXYS267, DXYS218, and DXS1187, the number of loci with intermediate peak patterns is <2; if all of the above are met, the sex chromosome type is interpreted as XX. Second interpretation rule: Locus AMEL is a normal peak or intermediate peak; locus TAF9B is a trisomy peak or intermediate peak; loci DXYS267 and DXYS218 are normal peaks, invalid peaks, or intermediate peaks; loci DXS981, DXS1187, and SRY are invalid peaks; locus DYS448 is a normal peak, invalid peak, no peak, or intermediate peak; if the number of intermediate peaks among loci AMEL, TAF9B, DXYS267, DXYS218, and DYS448 is less than 2; if all of the above conditions are met, the sex chromosome type is interpreted as XY. The third interpretation rule is as follows: Locus AMEL shows a trisomy peak or intermediate peak pattern; loci DXYS267 and DXYS218 show a trisomy peak, invalid peak, or intermediate peak pattern; loci DYS448 and SRY show invalid peak patterns; loci DXS981 and DXS1187 show a normal peak, invalid peak, or intermediate peak pattern; locus TAF9B shows a normal peak or intermediate peak pattern; if the number of intermediate peak patterns among loci AMEL, DXYS267, DXYS218, DXS981, DXS1187, and TAF9B is less than 2; if all of the above conditions are met, the sex chromosome type is interpreted as XXY positive. Fourth interpretation rule: AMEL locus shows an invalid peak pattern; DXYS267, DXYS218, DXS981, and DXS1187 loci show a trisomy peak pattern, an invalid peak pattern, or an intermediate peak pattern; SRY and DYS448 loci show no peak; TAF9B locus shows a normal peak pattern or an intermediate peak pattern; among DXYS267, DXYS218, DXS981, and DXS1187, the number of intermediate peak patterns is <2. If all of the above conditions are met, the sex chromosome typing is interpreted as XXX positive. Fifth interpretation rule: Locus AMEL shows a trisomy peak pattern or intermediate peak pattern; loci DXYS267 and DXYS218 show a trisomy peak pattern, invalid peak pattern, or intermediate peak pattern; locus DYS448 shows a normal peak pattern, invalid peak pattern, or intermediate peak pattern; locus TAF9B shows a trisomy peak pattern or intermediate peak pattern; loci DXS981, DXS1187, and SRY show invalid peak patterns; among loci AMEL, DXYS267, DXYS218, DYS448, and TAF9B, the number of loci with intermediate peak patterns is <2; if all of the above are met, the sex chromosome type is interpreted as XYY positive. Sixth interpretation rule: Loci AMEL, DXYS267, DXYS218, DXS981, and DXS1187 are all invalid peaks; locus TAF9B is a trisomy peak or an intermediate peak; loci SRY and DYS448 are peakless; locus TAF9B is not an intermediate peak; if all of the above are met, the sex chromosome type is interpreted as X monosomy. Seventh interpretation rule: If all loci conditions of any one of the following types are met: XX type, XY type, XXY positive, XXX positive, XYY positive, or X monosomy, and the number of loci with intermediate peaks is ≥2, then the sex chromosome type is interpreted as possibly sex chromosome mosaicism. Eighth interpretation rule: When loci AMEL, DYS448, and SRY are all invalid peaks, the interpretation is that the sex chromosome locus information is contradictory. Ninth interpretation rule: When there are ≥2 normal peaks and 1 trisomy peak, it is interpreted as a possible CNV on the sex chromosome; The tenth interpretation rule: If the peak distribution data of sex chromosome loci does not meet any of the above interpretation conditions, it shall be interpreted as a sex chromosome verification result. Attached Figure Description

[0018] To more clearly illustrate the specific embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.

[0019] Figure 1 This is a schematic diagram of the structure of an automated chromosome abnormality analysis system according to an embodiment of the present invention; Figure 2 This is a schematic diagram of the peak area ratio according to an embodiment of the present invention. Detailed Implementation

[0020] To make the objectives, technical solutions, and advantages of the embodiments of the present invention clearer, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0021] It is understood that before using the technical solutions disclosed in the various embodiments of the present invention, users should be informed of the types, scope of use, and usage scenarios of the personal information involved in the present invention and their authorization should be obtained in accordance with relevant laws and regulations through appropriate means.

[0022] The terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of this invention, "a plurality of" means two or more, unless otherwise explicitly specified.

[0023] Current mainstream STR data analysis methods not only heavily rely on manual interpretation but also lack standardization, making batch processing difficult.

[0024] Therefore, there is an urgent need to develop a system that can automatically analyze STR data and intelligently interpret chromosomal abnormalities in order to improve detection efficiency and accuracy.

[0025] Therefore, this embodiment provides an automated chromosome abnormality analysis system, such as... Figure 1 As shown, the system includes: a data reading and processing module 11, an intelligent analysis module 12, and an automatic diagnosis module 13.

[0026] The data reading and processing module is used to read the raw STR data to be analyzed; it is also used to preprocess the raw STR data to be analyzed, and then extract key parameters from the preprocessed STR data to obtain target standard data; the key parameters include loci and peak data.

[0027] The data reading and processing module supports automatically reading raw STR data in CSV format exported by GeneMapper (the raw STR data to be analyzed). Operators can also upload raw STR data in CSV format output by GeneMapper through the user interface.

[0028] Raw STR data typically contains raw, miscellaneous fields such as sample number, marker site name, fragment length, peak area, peak height, and fluorescence channels.

[0029] The data reading and processing module automatically performs preprocessing operations, such as automatically identifying and filtering valid data columns, and removing invalid data rows such as garbled characters, blank rows, and baseline noise peaks; it also sorts the valid data rows by sample and location, and completes standardization processing. Furthermore, it extracts two types of core key parameters from the preprocessed data: Locus parameters: including Marke name and chromosome identifier to which the locus belongs (D21S / D18S / D13S / DX / DY). Peak data parameters include the peak area of ​​all valid main peaks at the same location, the number of main peaks (the number of valid main peaks), and the peak height.

[0030] The cleaned and parameter-extracted structured data is packaged into target standard data and transmitted to the intelligent analysis module.

[0031] The intelligent analysis module, connected to the data reading and processing module, is used to determine the peak distribution data of loci on each group of chromosomes based on target standard data.

[0032] The target standard data prioritizes grouping loci according to chromosome type. For example, based on locus identifiers, all STR loci are automatically divided into chromosome 21 group, chromosome 18 group, chromosome 13 group, and sex chromosome group.

[0033] For each STR locus within a group, the determination is based on peak data. An example is provided below: Number of main peaks at loci = 0: Returns an empty value directly, without calculating the ratio; If the number of main peaks at a site is 1, the site is directly marked as an invalid peak type, and the ratio is not calculated. Number of main peaks at each site = 2: Calculate the peak area ratio (ratio) and match the peak shape with the preset ratio range: For example, the peak areas of a certain chromosome 21 locus are 18600 and 9200, and the peak area ratio is approximately 0.49, which satisfies 0.45≤ratio≤0.65, and is therefore determined to be a trisomic peak type. For example: if the peak area ratio at a certain point is 1.12, which satisfies 0.80≤ratio≤1.4, it is determined to be a normal peak shape; Number of main peaks at site = 3: Calculate the peak area ratio. If 1 ≤ ratio ≤ 1.4, it is determined to be a three-body peak type. The other ratio ranges are determined to be intermediate peak types.

[0034] The number of normal peak-shaped loci, trisomic peak-shaped loci, intermediate peak-shaped loci, and invalid peak-shaped loci are counted separately within each group of chromosomes to generate peak-shaped distribution data of loci on each group of chromosomes, which is then sent to the automatic diagnosis module.

[0035] The automatic diagnosis module, connected to the intelligent analysis module, is used to determine the chromosome analysis results for each group of chromosomes based on preset multi-level interpretation rules and the peak distribution data corresponding to each group of chromosomes.

[0036] Taking the peak distribution data of 7 STR loci on chromosome 21 as an example, a three-level multi-level interpretation rule is applied: Primary statistics: Peak distribution data show 2 three-body peak sites, 3 normal sites, 1 intermediate peak site, and 1 invalid site; Secondary threshold matching: Matching the interpretation rule for chromosome 21, "Trisomy peak pattern ≥ 2 loci, interpreted as trisomy 21 positive"; Level 3 output conclusion: Analysis of chromosome 21 showed a positive result for trisomy 21; Similarly, determine the groups for chromosomes 18, 13, and sex chromosomes, and output the final analysis results for each group of chromosomes (trisomy positive / trisomy negative / monosomal / potential mosaicism).

[0037] The automatic chromosome abnormality analysis system provided by this invention can automatically complete the entire process from importing the original CSV file to chromosomal abnormality diagnosis, eliminating the need for manual statistical analysis of locus peaks and greatly improving detection efficiency. Furthermore, by comprehensively interpreting the locus peak distribution data, it significantly reduces false positives and false negatives caused by errors at a single locus, resulting in a significant improvement in accuracy.

[0038] This embodiment provides an automated chromosome abnormality analysis system, such as Figure 2 As shown, the system includes: a data reading and processing module 21, an intelligent analysis module 22, an automatic diagnosis module 23, a result verification and editing module 24, and a report generation module 25.

[0039] The data reading and processing module is used to read the raw STR data to be analyzed; it is also used to preprocess the raw STR data to be analyzed, and then extract key parameters from the preprocessed STR data to obtain target standard data; the key parameters include loci and peak data. For a detailed description of the data reading and processing module, please refer to the previous embodiment, which will not be repeated here.

[0040] The intelligent analysis module, connected to the data reading and processing module, is used to determine the peak distribution data of loci on each group of chromosomes based on target standard data.

[0041] In some alternative implementations, the intelligent analysis module includes: The main peak number identification unit is used to identify the number of main peaks corresponding to each point on each chromosome group based on the target standard data.

[0042] The ratio calculation unit is used to calculate the first ratio and the second ratio of the corresponding site based on the target standard data, when the number of main peaks corresponding to the site is greater than 1; wherein, the first ratio is the ratio between the maximum peak area and the minimum peak area, and the second ratio is the ratio between the minimum peak area and the maximum peak area; the first ratio and the second ratio are used together as the peak area ratio.

[0043] The peak shape recognition unit is used to determine the peak shape of each point on each group of chromosomes based on the number of main peaks, the peak area ratio, and the preset chromosome multi-level ratio rules, and to generate peak shape distribution data.

[0044] In some alternative implementations, the peak shape recognition unit is specifically used for: If the number of main peaks is 0, return an empty value and skip the peak shape judgment.

[0045] When the number of main peaks is 1, the peak shape at the corresponding site is determined to be an invalid peak shape.

[0046] When the number of main peaks is greater than 1, the peak area ratio is matched with the corresponding preset chromosome multi-level ratio rule according to each chromosome type to determine the peak shape of the corresponding locus as one of the following: trisomy peak, intermediate peak, or normal peak. The preset chromosome multi-level ratio rule includes multiple ratio intervals divided according to the number of main peaks at the locus for different chromosome types, where each ratio interval corresponds to a peak shape.

[0047] Table 1 shows an example of a preset chromosome multilevel ratio rule applicable to chromosomes 18, 13, and 21.

[0048] Table 1

[0049] Table 2 shows an example of a preset chromosome multilevel ratio rule for applicable chromosomes.

[0050] Table 2

[0051] If either the first ratio or the second ratio falls within a matching ratio interval, the peak shape of the corresponding locus is determined based on the ratio falling within the interval; if both the first ratio and the second ratio fall within a matching ratio interval, the peak shape corresponding to the ratio interval in which the first ratio falls is taken as the peak shape of that locus; if neither the first ratio nor the second ratio falls within a matching ratio interval, the peak shape of the corresponding locus is determined based on the matching interval of the first ratio.

[0052] The following example uses chromosome 21: For sites with more than 1 main peaks, the calculation is performed to extract the peak area values ​​of all valid main peaks at that site, and the maximum peak area maxA and minimum peak area minA are selected. If the number of main peaks at a site is 0 or 1, the ratio calculation unit skips the calculation and does not output the ratio data.

[0053] Calculate the first ratio R1 = maxA / minA and the second ratio R2 = minA / maxA; package R1 and R2 into a peak area ratio for that site and pass it to the peak shape recognition unit.

[0054] For example: the peak areas of the two main peaks at the site are 18400 and 9100 respectively; R1=18400 / 9100≈2.02, R2=9100 / 18400≈0.49, and the set of peak area ratios is {2.02,0.49}; The first ratio of 2.02 and the second ratio of 0.49 are compared with the ratio intervals corresponding to the number of main peaks 2 in Table 1. The first ratio of 2.02 falls into the ratio interval of "1.8≤ratio≤2.4" and the second ratio of 0.49 falls into the ratio interval of "0.45≤ratio≤0.65". Therefore, the peak shape corresponding to this position is determined to be a three-body peak shape.

[0055] Similarly, the peak shape data of all loci on chromosome 21 are determined, and peak shape distribution data are generated.

[0056] The automatic diagnosis module, connected to the intelligent analysis module, is used to determine the chromosome analysis results for each group of chromosomes based on preset multi-level interpretation rules and the peak distribution data corresponding to each group of chromosomes.

[0057] In some optional implementations, when the chromosome is chromosome 21, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 21 on chromosome 21, the diagnosis is trisomy 21 positive. If there are 7 invalid peaks on chromosome 21, the diagnosis is either monosomy of chromosome 21 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 21, it is interpreted as possible trisomy 21 mosaicism. If there are ≥2 normal peaks on chromosome 21, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 21 and 6 invalid peaks, the diagnosis is trisomy 21 negative. If chromosome 21 does not meet any of the above conditions, the result should be interpreted as chromosome 21 requiring verification.

[0058] In one optional implementation, when the chromosome is chromosome 18, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 18 on chromosome 18, the diagnosis is trisomy 18 positive. If there are 5 invalid peaks on chromosome 18, the diagnosis is either monosomy of chromosome 18 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 18, it is interpreted as possible trisomy 18 mosaicism. If there are ≥2 normal peaks on chromosome 18, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 18 and 4 invalid peaks, the diagnosis is trisomy 18 negative. If chromosome 18 does not meet any of the above conditions, the result should be interpreted as chromosome 18 requiring verification.

[0059] In one optional implementation, when the chromosome is chromosome 13, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 13 peaks on chromosome 13, the diagnosis is trisomy 13 positive. If there are 5 invalid peaks on chromosome 13, the diagnosis is either monosomy of chromosome 13 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 13, it is interpreted as possible trisomy 13 mosaicism. If there are ≥2 normal peaks on chromosome 13, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 13 and 4 invalid peaks, the diagnosis is trisomy 13 negative. If chromosome 13 does not meet any of the above conditions, the result should be interpreted as chromosome 13 requiring verification.

[0060] In one optional implementation, when the chromosome is a sex chromosome, the preset multi-level interpretation rules include: First interpretation rule: Locus AMEL shows an invalid peak pattern; loci SRY and DYS448 show no peak; locus TAF9B shows a normal peak pattern or an intermediate peak pattern; loci DXS981, DXYS267, DXYS218, and DXS1187 show a normal peak pattern, an invalid peak pattern, or an intermediate peak pattern; among loci TAF9B, DXS981, DXYS267, DXYS218, and DXS1187, the number of loci with intermediate peak patterns is <2; if all of the above are met, the sex chromosome type is interpreted as XX. Second interpretation rule: Locus AMEL is a normal peak or intermediate peak; locus TAF9B is a trisomy peak or intermediate peak; loci DXYS267 and DXYS218 are normal peaks, invalid peaks, or intermediate peaks; loci DXS981, DXS1187, and SRY are invalid peaks; locus DYS448 is a normal peak, invalid peak, no peak, or intermediate peak; if the number of intermediate peaks among loci AMEL, TAF9B, DXYS267, DXYS218, and DYS448 is less than 2; if all of the above conditions are met, the sex chromosome type is interpreted as XY. The third interpretation rule is as follows: Locus AMEL shows a trisomy peak or intermediate peak pattern; loci DXYS267 and DXYS218 show a trisomy peak, invalid peak, or intermediate peak pattern; loci DYS448 and SRY show invalid peak patterns; loci DXS981 and DXS1187 show a normal peak, invalid peak, or intermediate peak pattern; locus TAF9B shows a normal peak or intermediate peak pattern; if the number of intermediate peak patterns among loci AMEL, DXYS267, DXYS218, DXS981, DXS1187, and TAF9B is less than 2; if all of the above conditions are met, the sex chromosome type is interpreted as XXY positive. Fourth interpretation rule: AMEL locus shows an invalid peak pattern; DXYS267, DXYS218, DXS981, and DXS1187 loci show a trisomy peak pattern, an invalid peak pattern, or an intermediate peak pattern; SRY and DYS448 loci show no peak; TAF9B locus shows a normal peak pattern or an intermediate peak pattern; among DXYS267, DXYS218, DXS981, and DXS1187, the number of intermediate peak patterns is <2. If all of the above conditions are met, the sex chromosome typing is interpreted as XXX positive. Fifth interpretation rule: Locus AMEL shows a trisomy peak pattern or intermediate peak pattern; loci DXYS267 and DXYS218 show a trisomy peak pattern, invalid peak pattern, or intermediate peak pattern; locus DYS448 shows a normal peak pattern, invalid peak pattern, or intermediate peak pattern; locus TAF9B shows a trisomy peak pattern or intermediate peak pattern; loci DXS981, DXS1187, and SRY show invalid peak patterns; among loci AMEL, DXYS267, DXYS218, DYS448, and TAF9B, the number of loci with intermediate peak patterns is <2; if all of the above are met, the sex chromosome type is interpreted as XYY positive. Sixth interpretation rule: Loci AMEL, DXYS267, DXYS218, DXS981, and DXS1187 are all invalid peaks; locus TAF9B is a trisomy peak or an intermediate peak; loci SRY and DYS448 are peakless; locus TAF9B is not an intermediate peak; if all of the above are met, the sex chromosome type is interpreted as X monosomy. Seventh interpretation rule: If all loci conditions of any one of the following types are met: XX type, XY type, XXY positive, XXX positive, XYY positive, or X monosomy, and the number of loci with intermediate peaks is ≥2, then the sex chromosome type is interpreted as possibly sex chromosome mosaicism. Eighth interpretation rule: When loci AMEL, DYS448, and SRY are all invalid peaks, the interpretation is that the sex chromosome locus information is contradictory. Ninth interpretation rule: When there are ≥2 normal peaks and 1 trisomy peak, it is interpreted as a possible CNV on the sex chromosome; The tenth interpretation rule: If the peak distribution data of sex chromosome loci does not meet any of the above interpretation conditions, it shall be interpreted as a sex chromosome verification result.

[0061] The result verification and editing module is used to visually display the output data of at least one of the data reading and processing module, intelligent analysis module, and automatic diagnosis module; it is also used to respond to user operation commands to enable data editing.

[0062] The results review and editing module can visually display all locus ratios, peak shapes, and chromosome analysis results for each group, and supports technicians to manually correct misjudged loci, with the entire modification history recorded.

[0063] The report generation module is used to receive output data from at least one of the data reading and processing module, intelligent analysis module, automatic diagnosis module, and result review and editing module, and generate a standardized diagnostic report based on the received data.

[0064] The report generation module can integrate raw data, ratio calculation records, peak distribution data, and chromosome analysis results, and supports exporting detailed Excel spreadsheets, standardized Word reports, and PDF reports. Some standardized diagnostic reports are shown in Table 3.

[0065] Table 3

[0066] This invention enables automated analysis and intelligent interpretation of STR data, significantly reducing the analysis time for a single sample, improving the efficiency and accuracy of prenatal chromosome analysis, and supporting batch processing and standardized report output, thereby enhancing the consistency of analysis results.

[0067] Although embodiments of the invention have been described in conjunction with the accompanying drawings, those skilled in the art can make various modifications and variations without departing from the spirit and scope of the invention, and such modifications and variations all fall within the scope defined by the appended claims.

Claims

1. An automated chromosomal abnormality analysis system based on STR data, characterized in that, The system includes: The data reading and processing module is used to read the raw STR data to be analyzed; it is also used to preprocess the raw STR data to be analyzed, and then extract key parameters from the preprocessed STR data to obtain target standard data; the key parameters include loci and peak data; The intelligent analysis module, connected to the data reading and processing module, is used to determine the peak distribution data of each chromosome locus based on the target standard data. An automatic diagnosis module, connected to the intelligent analysis module, is used to determine the chromosome analysis result for each group of chromosomes based on preset multi-level interpretation rules and the peak distribution data corresponding to each group of chromosomes.

2. The system according to claim 1, characterized in that, The system also includes: The result verification and editing module is used to visually display the output data of at least one of the data reading and processing module, the intelligent analysis module, and the automatic diagnosis module; it is also used to respond to user operation commands to enable data editing. The report generation module is used to receive output data from at least one of the data reading and processing module, the intelligent analysis module, the automatic diagnosis module, and the result review and editing module, and generate a standardized diagnostic report based on the received data.

3. The system according to claim 1, characterized in that, The intelligent analysis module includes: The main peak number identification unit is used to identify the number of main peaks corresponding to each point on each chromosome based on the target standard data. The ratio calculation unit is used to determine the peak area ratio of the corresponding site based on the target standard data, when the number of main peaks corresponding to the site is greater than 1. The peak shape recognition unit is used to determine the peak shape of each point on each group of chromosomes based on the number of main peaks, the peak area ratio and the preset chromosome multi-level ratio rule, and generate the peak shape distribution data.

4. The system according to claim 3, characterized in that, The peak shape recognition unit is specifically used for: If the number of main peaks is 0, skip the peak shape determination and return an empty value; When the number of main peaks is 1, the peak shape at the corresponding location is determined to be an invalid peak shape; When the number of main peaks is greater than 1, the peak area ratio is matched with the corresponding preset chromosome multi-level ratio rule according to each chromosome type to determine that the peak shape of the corresponding site is one of the three-body peak shape, intermediate peak shape, or normal peak shape.

5. The system according to claim 4, characterized in that, The preset chromosome multi-level ratio rule includes multiple ratio intervals divided according to the number of main peaks at different chromosome types, wherein each ratio interval corresponds to a peak type.

6. The system according to claim 4, characterized in that, The ratio calculation unit is specifically used for: When the number of main peaks corresponding to a site is greater than 1, calculate the first ratio and the second ratio of the corresponding site; wherein, the first ratio is the ratio between the maximum peak area and the minimum peak area, and the second ratio is the ratio between the minimum peak area and the maximum peak area; The first ratio and the second ratio are used together as the peak area ratio.

7. The system according to claim 4, characterized in that, In the case of chromosome 21, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 21 on chromosome 21, the diagnosis is trisomy 21 positive. If there are 7 invalid peaks on chromosome 21, the diagnosis is either monosomy of chromosome 21 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 21, it is interpreted as possible trisomy 21 mosaicism. If there are ≥2 normal peaks on chromosome 21, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 21 and 6 invalid peaks, the diagnosis is trisomy 21 negative. If chromosome 21 does not meet any of the above conditions, the result should be interpreted as chromosome 21 requiring verification.

8. The system according to claim 4, characterized in that, In the case of chromosome 18, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 18 on chromosome 18, the diagnosis is trisomy 18 positive. If there are 5 invalid peaks on chromosome 18, the diagnosis is either monosomy of chromosome 18 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 18, it is interpreted as possible trisomy 18 mosaicism. If there are ≥2 normal peaks on chromosome 18, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 18 and 4 invalid peaks, the diagnosis is trisomy 18 negative. If chromosome 18 does not meet any of the above conditions, the result should be interpreted as chromosome 18 requiring verification.

9. The system according to claim 4, characterized in that, In the case of chromosome 13, the preset multi-level interpretation rules include: If there are ≥2 sites of trisomy 13 peaks on chromosome 13, the diagnosis is trisomy 13 positive. If there are 5 invalid peaks on chromosome 13, the diagnosis is either monosomy of chromosome 13 or uniparental disomy. If there are ≥3 intermediate peaks on chromosome 13, it is interpreted as possible trisomy 13 mosaicism. If there are ≥2 normal peaks on chromosome 13, and 0 trisomy peaks, and ≤2 intermediate peaks, or if there is 1 normal peak on chromosome 13 and 4 invalid peaks, the diagnosis is trisomy 13 negative. If chromosome 13 does not meet any of the above conditions, the result should be interpreted as chromosome 13 requiring verification.

10. The system according to claim 4, characterized in that, When the chromosome is a sex chromosome, the preset multi-level interpretation rules include: First interpretation rule: Locus AMEL shows an invalid peak pattern; loci SRY and DYS448 show no peak; locus TAF9B shows a normal peak pattern or an intermediate peak pattern; loci DXS981, DXYS267, DXYS218, and DXS1187 show a normal peak pattern, an invalid peak pattern, or an intermediate peak pattern; among loci TAF9B, DXS981, DXYS267, DXYS218, and DXS1187, the number of loci with intermediate peak patterns is <2; if all of the above are met, the sex chromosome type is interpreted as XX. Second interpretation rule: Locus AMEL is a normal peak or intermediate peak; locus TAF9B is a trisomy peak or intermediate peak; loci DXYS267 and DXYS218 are normal peaks, invalid peaks, or intermediate peaks; loci DXS981, DXS1187, and SRY are invalid peaks; locus DYS448 is a normal peak, invalid peak, no peak, or intermediate peak; if the number of intermediate peaks among loci AMEL, TAF9B, DXYS267, DXYS218, and DYS448 is less than 2; if all of the above conditions are met, the sex chromosome type is interpreted as XY. The third interpretation rule is as follows: Locus AMEL shows a trisomy peak or intermediate peak pattern; loci DXYS267 and DXYS218 show a trisomy peak, invalid peak, or intermediate peak pattern; loci DYS448 and SRY show invalid peak patterns; loci DXS981 and DXS1187 show a normal peak, invalid peak, or intermediate peak pattern; locus TAF9B shows a normal peak or intermediate peak pattern; if the number of intermediate peak patterns among loci AMEL, DXYS267, DXYS218, DXS981, DXS1187, and TAF9B is less than 2; if all of the above conditions are met, the sex chromosome type is interpreted as XXY positive. Fourth interpretation rule: AMEL locus shows an invalid peak pattern; DXYS267, DXYS218, DXS981, and DXS1187 loci show a trisomy peak pattern, an invalid peak pattern, or an intermediate peak pattern; SRY and DYS448 loci show no peak; TAF9B locus shows a normal peak pattern or an intermediate peak pattern; among DXYS267, DXYS218, DXS981, and DXS1187, the number of intermediate peak patterns is <2. If all of the above conditions are met, the sex chromosome typing is interpreted as XXX positive. Fifth interpretation rule: Locus AMEL shows a trisomy peak pattern or intermediate peak pattern; loci DXYS267 and DXYS218 show a trisomy peak pattern, invalid peak pattern, or intermediate peak pattern; locus DYS448 shows a normal peak pattern, invalid peak pattern, or intermediate peak pattern; locus TAF9B shows a trisomy peak pattern or intermediate peak pattern; loci DXS981, DXS1187, and SRY show invalid peak patterns; among loci AMEL, DXYS267, DXYS218, DYS448, and TAF9B, the number of loci with intermediate peak patterns is <2; if all of the above are met, the sex chromosome type is interpreted as XYY positive. Sixth interpretation rule: Loci AMEL, DXYS267, DXYS218, DXS981, and DXS1187 are all invalid peaks; locus TAF9B is a trisomy peak or an intermediate peak; loci SRY and DYS448 are peakless; locus TAF9B is not an intermediate peak; if all of the above are met, the sex chromosome type is interpreted as X monosomy. Seventh interpretation rule: If all loci conditions of any one of the following types are met: XX type, XY type, XXY positive, XXX positive, XYY positive, or X monosomy, and the number of loci with intermediate peaks is ≥2, then the sex chromosome type is interpreted as possibly sex chromosome mosaicism. Eighth interpretation rule: When loci AMEL, DYS448, and SRY are all invalid peaks, the interpretation is that the sex chromosome locus information is contradictory. Ninth interpretation rule: When there are ≥2 normal peaks and 1 trisomy peak, it is interpreted as a possible CNV on the sex chromosome; The tenth interpretation rule: If the peak distribution data of sex chromosome loci does not meet any of the above interpretation conditions, it shall be interpreted as a sex chromosome verification result.